Insider Shareholders with Direct Ownership of Mineralys Therapeutics, Inc. (MLYS)
This section provides a comprehensive overview of the insiders with direct ownership of Mineralys Therapeutics, Inc. (MLYS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Mineralys Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Hbm Healthcare Investments (Cayman) Ltd.
> 10% Shareholder |
3,218,106 | 0 | 3,218,106 | 1 |
Feb 14, 2023
Added 8.85%
|
|
Jon Congleton
Chief Executive Officer |
34,832 | 433,999 | 639,151 | 19 |
Jan 12, 2026
Reduced 1.1%
|
|
David Malcom Rodman
Chief Medical Officer |
731,974 | 687,531 | 50,437 | 61 |
Jan 14, 2026
Reduced 18.39%
|
|
Adam Scott Levy
CFO and Secretary |
111,903 | 365,319 | 8,638 | 14 |
Jan 12, 2026
Reduced 55.47%
|
|
Daphne Karydas
Director |
15,000 | 15,000 | 0 | 2 |
Nov 13, 2025
Reduced 100.0%
|
|
Alexander M Gold
Director |
34,675 | 34,675 | 0 | 6 |
Nov 13, 2025
Reduced 100.0%
|